Join us for an insightful webinar where two pioneering leaders share their journeys from academia to the forefront of cardiovascular innovation. Discover their experiences, challenges, and the breakthroughs they’re driving in the field of heart health.
Our Speakers:
David, Founder and CEO of GenKardia Inc., has over 18 years of experience in molecular cardiology. He earned his BSc from Carnegie Mellon University and a PhD from Rutgers Medical School, followed by postdoctoral fellowships at Harvard Medical School and the Max Planck Institute. Transitioning into industry, David worked at AstraZeneca and Novo Nordisk, identifying new heart failure targets. In 2022, he founded GenKardia Inc. to push the boundaries of cardiovascular therapeutics.
Dr. Richard Nkulikiyinka, Chief Development Officer and Chief Medical Officer, brings 20 years of experience in clinical practice and pharmaceutical R&D. A graduate of the University of Cambridge with a medical degree and a Masters in Epidemiology from the London School of Hygiene and Tropical Medicine, Richard has held leadership roles at Bayer, including Vice President, Head of Therapeutic Area Cardiology, Nephrology, and Pulmonology. He has guided numerous Phase III clinical trials and led the approval of groundbreaking therapies.
#biotech #cardiovascular #startup #founder #pharma #therapeutics #innovation
